Literature DB >> 25092712

Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.

Frederik Boetius Hertz1, Anders Løbner-Olesen2, Niels Frimodt-Møller3.   

Abstract

The ability of different antibiotics to select for extended-spectrum β-lactamase (ESBL)-producing Escherichia coli remains a topic of discussion. In a mouse intestinal colonization model, we evaluated the selective abilities of nine common antimicrobials (cefotaxime, cefuroxime, dicloxacillin, clindamycin, penicillin, ampicillin, meropenem, ciprofloxacin, and amdinocillin) against a CTX-M-15-producing E. coli sequence type 131 (ST131) isolate with a fluoroquinolone resistance phenotype. Mice (8 per group) were orogastrically administered 0.25 ml saline with 10(8) CFU/ml E. coli ST131. On that same day, antibiotic treatment was initiated and given subcutaneously once a day for three consecutive days. CFU of E. coli ST131, Bacteroides, and Gram-positive aerobic bacteria in fecal samples were studied, with intervals, until day 8. Bacteroides was used as an indicator organism for impact on the Gram-negative anaerobic population. For three antibiotics, prolonged colonization was investigated with additional fecal CFU counts determined on days 10 and 14 (cefotaxime, dicloxacillin, and clindamycin). Three antibiotics (cefotaxime, dicloxacillin, and clindamycin) promoted overgrowth of E. coli ST131 (P < 0.05). Of these, only clindamycin suppressed Bacteroides, while the remaining two antibiotics had no negative impact on Bacteroides or Gram-positive organisms. Only clindamycin treatment resulted in prolonged colonization. The remaining six antibiotics, including ciprofloxacin, did not promote overgrowth of E. coli ST131 (P > 0.95), nor did they suppress Bacteroides or Gram-positive organisms. The results showed that antimicrobials both with and without an impact on Gram-negative anaerobes can select for ESBL-producing E. coli, indicating that not only Gram-negative anaerobes have a role in upholding colonization resistance. Other, so-far-unknown bacterial populations must be of importance for preventing colonization by incoming E. coli.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25092712      PMCID: PMC4187947          DOI: 10.1128/AAC.03021-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.

Authors:  Ghizlane Dahbi; Azucena Mora; Cecilia López; María Pilar Alonso; Rosalía Mamani; Juan Marzoa; Amparo Coira; Fernando García-Garrote; Julia María Pita; David Velasco; Alexandra Herrera; Susana Viso; Jesús E Blanco; Miguel Blanco; Jorge Blanco
Journal:  Int J Antimicrob Agents       Date:  2013-08-29       Impact factor: 5.283

2.  Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Juan C Alcalá; Jose M Cisneros; Fabio Grill; Antonio Oliver; Juan P Horcajada; Teresa Tórtola; Beatriz Mirelis; Gemma Navarro; María Cuenca; María Esteve; Carmen Peña; Ana C Llanos; Rafael Cantón; Alvaro Pascual
Journal:  Arch Intern Med       Date:  2008-09-22

3.  Improved performance of bacterium and yeast identification by a commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry system in the clinical microbiology laboratory.

Authors:  John Haigh; Amarjeet Degun; Melvyn Eydmann; Michael Millar; Mark Wilks
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

4.  Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.

Authors:  Lotte Jakobsen; Vincent Cattoir; Klaus S Jensen; Anette M Hammerum; Patrice Nordmann; Niels Frimodt-Møller
Journal:  J Antimicrob Chemother       Date:  2012-06-08       Impact factor: 5.790

5.  Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.

Authors:  Federico Perez; Michael J Pultz; Andrea Endimiani; Robert A Bonomo; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

6.  Changes of viability and composition of the Escherichia coli flora in faecal samples during long time storage.

Authors:  S J Achá; I Kühn; G Mbazima; Patricia Colque-Navarro; R Möllby
Journal:  J Microbiol Methods       Date:  2005-06-24       Impact factor: 2.363

7.  Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

Authors:  Jesús Rodríguez-Baño; Maria D Navarro; Luisa Romero; Miguel A Muniain; Marina de Cueto; María J Ríos; José R Hernández; Alvaro Pascual
Journal:  Clin Infect Dis       Date:  2006-10-25       Impact factor: 9.079

8.  Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection.

Authors:  Karen L Nielsen; Pia Dynesen; Preben Larsen; Niels Frimodt-Møller
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome.

Authors:  Lukasz Krych; Camilla H F Hansen; Axel K Hansen; Frans W J van den Berg; Dennis S Nielsen
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

View more
  13 in total

1.  Impact of the Timing of Antibiotic Administration on Digestive Colonization with Carbapenemase-Producing Enterobacteriaceae in a Murine Model.

Authors:  Rémi Le Guern; Teddy Grandjean; Marvin Bauduin; Martin Figeac; Guillaume Millot; Aurore Loquet; Karine Faure; Eric Kipnis; Rodrigue Dessein
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

3.  Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.

Authors:  Josef D Järhult; Linus Sandegren; Clara Atterby; Marie Nykvist; Ulrika Lustig; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  Impact of ceftiofur injection on gut microbiota and Escherichia coli resistance in pigs.

Authors:  M A Fleury; G Mourand; E Jouy; F Touzain; L Le Devendec; C de Boisseson; F Eono; R Cariolet; A Guérin; O Le Goff; S Blanquet-Diot; M Alric; I Kempf
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

5.  A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment.

Authors:  Matthieu Grégoire; Florian Berteau; Ronan Bellouard; Quentin Lebastard; Philippe Aubert; Jacques Gonzales; François Javaudin; Anne Bessard; Pascale Bemer; Éric Batard; Didier Lepelletier; Michel Neunlist; Emmanuel Montassier; Éric Dailly
Journal:  Comput Struct Biotechnol J       Date:  2021-03-04       Impact factor: 7.271

6.  Acacia Fiber Protects the Gut from Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Colonization Enabled by Antibiotics.

Authors:  Brad Spellberg; Brian Luna; Marlène Maeusli; Nicholas Skandalis; Bosul Lee; Peggy Lu; Sarah Miller; Jun Yan; Yuli Talyansky; Rachel Li; Zeferino Reyna; Noel Guerrero; Amber Ulhaq; Matthew Slarve; Ioannis Theologidis
Journal:  mSphere       Date:  2022-05-18       Impact factor: 5.029

7.  Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.

Authors:  Muhanad Mohamed; Connie Clabots; Stephen B Porter; Paul Thuras; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2).

Authors:  Walter Zingg; Benjamin J Park; Julie Storr; Raheelah Ahmad; Carolyn Tarrant; Enrique Castro-Sanchez; Eli Perencevich; Andreas Widmer; Karl-Heinz Krause; Claire Kilpatrick; Sara Tomczyk; Benedetta Allegranzi; Denise Cardo; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-22       Impact factor: 4.887

9.  Effects of Antibiotics on the Intestinal Microbiota of Mice.

Authors:  Frederik Boetius Hertz; Andries E Budding; Malieka van der Lugt-Degen; Paul H Savelkoul; Anders Løbner-Olesen; Niels Frimodt-Møller
Journal:  Antibiotics (Basel)       Date:  2020-04-17

10.  Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome.

Authors:  Marlène Maeusli; Bosul Lee; Sarah Miller; Zeferino Reyna; Peggy Lu; Jun Yan; Amber Ulhaq; Nicholas Skandalis; Brad Spellberg; Brian Luna
Journal:  mSphere       Date:  2020-05-27       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.